International Clinical Trial: A Randomized, Open-label, Positive-controlled, Parallel-grouped, Multicenter Phase III Clinical Trial on the Efficacy and Safety of Flonoltinib Maleate Tablets in Patients With Intermediate- or High-risk Myelofibrosis

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118347) titled 'A Randomized, Open-label, Positive-controlled, Parallel-grouped, Multicenter Phase III Clinical Trial on the Efficacy and Safety of Flonoltinib Maleate Tablets in Patients With Intermediate- or High-risk Myelofibrosis' on Feb. 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences (IHCAMS);West China Hospital of Sichuan University

Condition: Myelofibrosis

Intervention: Experimental group:Flonoltinib 75mg

Recruitment Status: Not Recruiting

Phase: 3

Date of First Enrollment: 2026-02-27

Target Sa...